Wilson Jason Douglas 4
4 · REATA PHARMACEUTICALS INC · Filed Oct 21, 2019
Insider Transaction Report
Form 4
Wilson Jason Douglas
See Remarks
Transactions
- Conversion
Class A common stock
2019-10-17+10,000→ 17,350 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-10-17−10,000→ 44,881 totalExercise: $11.00Exp: 2026-05-25→ Class B common stock (10,000 underlying) - Conversion
Class B common stock
2019-10-17−10,000→ 18,827 total→ Class A common stock (10,000 underlying) - Sale
Class A common stock
2019-10-17$170.00/sh−10,000$1,700,000→ 7,350 total - Exercise/Conversion
Class B common stock
2019-10-17$11.00/sh+10,000$110,000→ 28,827 total→ Class A common stock (10,000 underlying)
Footnotes (3)
- [F1]The exercise, conversion, and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]The options, representing a right to purchase a total of 101,881 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016, subject to continued service through each vesting date.